Indication

Post-Acute Sequela of COVID-19

1 clinical trial

1 product

Clinical trial

An Exploratory, Randomized, Double-Blind Placebo-Controlled Study to Assess the Safety of an Anti-SARS-CoV-2 Monoclonal Antibody and Response to Treatment in Individuals With Long COVID (outSMART-LC)

Status: Active (not recruiting), Estimated PCD: 2025-07-31

Product